Table 1 Table 1
From: Role of inflammation in the pathogenesis of hypertrophic cardiomyopathy: a T2-mapping CMR study
| Â | Hypertrophic Cardiomyopathy | Controls | P Value |
|---|---|---|---|
N | 22 | 22 | Â |
Male | 15 | 9 | NS |
Age (years) | 55.8±8.7 | 49.3±13.1 | NS |
LV-EDV (ml) | 138.6±33.0 | 141.2±32.0 | NS |
LV ESV (ml) | 37.5±14.5 | 45.0±15.1 | NS |
Indexed LV-EDV (g/m 2 ) | 68.7±11.2 | 78.1±12.9 | 0.02 |
Indexed LV-ESV (g/m 2 ) | 18.5±6.4 | 24.7±6.8 | 0.004 |
Ejection Fraction (%) | 73.5±6.1 | 68.8±5.5 | 0.01 |
LV Mass | 185.9±68.2 | 105.0±30.8 | <0.001 |
Indexed LV Mass (g/m 2 ) | 92.6±33.8 | 57.8±12.5 | <0.001 |
Maximum Wall Thickness (mm) | 18.8±4.9 | 7.8±1.2 | <0.001 |